The narrow therapeutic window of glycated hemoglobin and assay variability

Metabolism: Clinical and Experimental

Volumn 48, Issue 12, 1999, Pages 1498-1502

  Hosseini, Seyed S ^a   Bibler, Irma ^a   Charles, M Arthur ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ARTICLE; GEL ELECTROPHORESIS; HEMOGLOBIN DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; VASCULAR DISEASE;

EID: 0032714927     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90236-6     Document Type: Article

References (23)

1. Garlick RL, Mazer JS, Higgins PJ, et al: Characterization of glycosylated hemoglobins. J Clin Invest 71:1062-1072, 1983
2. Nathan DM, Singer DE, Hurxthal K, et al: The clinical information value of the glycosylated hemoglobin assay. N Engl J Med 310:341-346, 1984
3. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
4. Goldstein DE, Little RR, Wiedmeyer H, et al: Glycated hemoglobin estimation in the 1990's: A review of assay methods and clinical interpretation, in Marshal SM, Home PD (eds): The Diabetes Annual (ed 8). Newcastle Upon Tyne, UK, Elsevier, 1994, pp 193-212
5. Benjamin RJ, Sacks DB: Glycated protein update: Implications of recent studies, including the Diabetes Control and Complications Trial. Clin Chem 40:683-687, 1994
6. Tuttleman M, Lipsett L, Harris MI: Attitudes and behaviors of primary care physicians regarding tight control of blood glucose in IDDM patients. Diabetes Care 16:765-772, 1993
7. Weiner JP, Parente ST, Garnick DW, et al: Variation in office-based quality. A claims-based profile of care provided to Medicare patients with diabetes. JAMA 273:1503-1508, 1995
8. Little R, Wiedmeyer H, England J, et al: Interlaboratory standardization of measurements of glycohemoglobins. Clin Chem 38:2472-2478, 1992
9. Kullberg C, Bergstrom A, Dinesen B, et al: Comparisons of studies on diabetic complications hampered by differences in GHb measurements. Diabetes Care 19:726-729, 1996
10. The Diabetes Control and Complications Trial Research Group: The absence of a glycemic threshold for the development of long-term complications: The perspective of the Diabetes Control and Complications Trial. Diabetes 45:1289-1298, 1996
11. Ohkubo Y, Kishikawa H, Araki E, et al: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study. Diabetes Res Clin Pract 28:103-117, 1995
12. UK Prospective Diabetes Study: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
13. The American Diabetes Association: Standards of medical care for patients with diabetes mellitus. Diabetes Care 22:S32, 1999 (suppl 1)
14. Monte M, Bevzard Y, Rosa J: Mapping of severe abnormal hemoglobins by polyacrylamide gel isoelectric focusing. Am J Clin Pathol 66:753-759, 1976
15. Olsen C, Liu G, Iravani M, et al: Long-term safety and efficacy of programmable implantable insulin delivery systems. Int J Artif Organs 16:847-854, 1993
16. Selam J, Micossi P, Dunn F, et al: Clinical trial of programmable insulin pump for type I diabetes. Diabetes Care 15:877-885, 1992
17. Anderson RM, Donnelly MB, Davis WK: Controversial beliefs about diabetes and its care. Diabetes Care 15:859-863, 1992
18. The Diabetes Control and Complications Trial Research Group: Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 46:271-286, 1997
19. Turner RC, Millns H, Neil HAW, et al: Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPD:23). BMJ 316:823-828, 1998
20. The Diabetes Control and Complications Trial Research Group: The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 44:968-983, 1994
21. Davis JE, McDonald JM, Jarett L: A high performance liquid chromatography method for haemoglobin A1c. Diabetes 27:102-107, 1978
22. Wei M, Gaskill SP, Haffner SM, et al: Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. Diabetes Care 21:1167-1172, 1998
23. Lowe LP, Liu K, Greenland P, et al: Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men: The Chicago Heart Association Detection Project in Industry Study. Diabetes Care 20:163-169, 1997